Space agency partners with the Office of Personnel Management (OPM) to recruit private sector workers for temporary roles.
Dal research teams are receiving more than $7.3M in Canada Foundation for Innovation support to expand labs and tools driving breakthroughs in water resilience, ocean science, marine tracking, and dig ...
Zacks Investment Research on MSN
AECOM stock plunges 29.7% in 6 months: Should you buy the dip?
AECOM ACM, a leading global infrastructure consulting firm, has experienced a sharp correction in recent months. Over the ...
Deutsche Post (DHLGY) is attractively valued amid geopolitical turmoil, trading near 12x FY2027 earnings with a strong competitive moat and scale advantages. Efficiency gains, automation, and ...
The CRN 2026 Partner Program Guide takes a look at how partner programs changed over the last 12 months to incorporate or support the selling of AI solutions by channel Partners.
Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:00 AM EDTCompany ParticipantsMark Kaye - Executive VP ...
Atos Group has Delivered on its Commitments to Restore its Foundations Growth Chapter Ready to be Opened FY 2025 financial and extra financial targets met or exceeded: Revenue at €8,001 million, ...
Indoor Golf, Women's Choice Awards, Music Honors & more - In The Know 3-1 ...
Advanced practice providers expand access by conducting initial consults, ordering diagnostic workups, explaining anti-amyloid risk–benefit tradeoffs, and coordinating multidisciplinary stakeholders ...
Vuzix Corporation (NASDAQ:VUZI) Q4 2025 Earnings Call Transcript March 12, 2026 Vuzix Corporation misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.09. Operator: ...
Expanded into AI-resilient growth channels through enhanced mobile in-app capabilities and the release of Nexxen’s industry-first programmatic Smart TV home screen ad activation solution, which is now ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results